James Bosley, PhD

SVP modeling & Simulation
Nova in silico

Poster(s):

• (M-019) In silico validation of MARIPOSA trial outcomes in EGFR‑mutated NSCLC using a QSP‑based disease model integrated with a newly implemented lazertinib drug model
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT